Loading the section…

VSTM: financial statements from SEC — TradeAlmanac

VSTM

Verastem, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	19M	11M	2M	—	—	10M
Research and development	38M	29M	25M	29M	25M	18M
Selling, general and administrative	22M	21M	21M	15M	12M	10M
Operating expenses	64M	52M	46M	44M	37M	28M
Operating income	−45M	−41M	−44M	−44M	−37M	−18M
Interest expense	382,000	319,000	212,000	192,000	1M	1M
Net income	−37M	−99M	−26M	−52M	−24M	−8M
Earnings per share	−0.37	−1.35	−0.39	−0.96	−0.60	−0.31
Earnings per share, diluted	−0.46	−1.35	−0.62	−0.96	−0.60	−0.31
Weighted average shares	98M	73M	66M	54M	40M	27M
Weighted average shares, diluted	99M	73M	74M	54M	40M	27M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	166M	205M	138M	164M	118M	89M	113M	84M
Short-term investments	16M	—

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−52M	−39M
Depreciation and amortisation	—	10,000
Share-based compensation	2M	2M
Investing cash flow	−16M	—
Financing cash flow	29M	67M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator